VRCA — Verrica Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $60.64m
- $50.84m
- $35.58m
Verrica Pharmaceuticals Inc expected to post a loss of 70 cents a share - Earnings Preview
Brief: Verrica Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide A Corporate Update On August 12, 2025
Brief: Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025
Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Verrica Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025
Verrica Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Verrica Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview
Verrica Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Brief: Verrica Announces Pricing Of $42.0 Million Public Offering
Brief: Verrica Announces Proposed Public Offering
Verrica Pharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Verrica Pharmaceuticals Says As Result Of Craig Ballaron's Resignation, Co Temporarily Not In Compliance With Nasdaq Listing Requirements
Brief: Verrica Pharmaceuticals Announces Reduction Of Its Workforce By 47 Employees
U.S. RESEARCH ROUNDUP-Allstate, Bluebird Bio, Vicinity Motor
U.S. STOCKS ON THE MOVE-Progressive, Serve Robotics, Palo Alto Networks
U.S. STOCKS ON THE MOVE-Allstate, Progressive, Serve Robotics